简介内容:KVI-020 is a selective, orally active blocker of the atrial potassium channel (IC50: 480 nM). kVI-020 exhibits inhibition of hERG (IC50: 15100 nM). KVI-020 is a potent antiarrhythmic agent and can be used in the study of atrial fibrillation (AF).